Arrêt de service programmé du vendredi 10 juin 16h jusqu’au lundi 13 juin 9h. Pour en savoir plus
Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Pronase treatment improves flow cytometry crossmatching results

Abstract : Flow cytometry crossmatching (FC-XM) is the most sensitive cell-based method for detecting donor-specific antibodies in clinical organ transplantation. Unfortunately, background FC-XM reactivity is elevated in assays with B lymphocytes-partly because of nonspecific immunoglobulin binding by Fc receptors and B-cell surface immunoglobulins. To reduce the background reactivity in a B-cell FC-XM assay, we treated lymphocytes with pronase (1 mg/mL for 30 minutes). This treatment drastically reduced the presence of kappa light chains and Fc receptors (CD32b), while the concomitant decrease in CD19, CD20 and major histocompatibility complex (MHC) I and II expression on B-cells was acceptable. Higher pronase concentrations (>2 mg/mL) started to significantly affect CD19, CD20, MHC-I and -II expression on B-cells. In subsequent prospective experiments (on 42 donor cells tested with 102 sera), we found that pronase treatment was associated with a relative increase of the sensitivity and specificity in our B-cell FC-XM assay.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal-u-picardie.archives-ouvertes.fr/hal-03574251
Contributeur : Louise Dessaivre Connectez-vous pour contacter le contributeur
Soumis le : mardi 15 février 2022 - 09:23:46
Dernière modification le : jeudi 17 février 2022 - 03:38:05

Identifiants

Citation

M. -J. Apithy, J. Desoutter, A. Gicquel, E. Guiheneuf, P. -F. Westeel, et al.. Pronase treatment improves flow cytometry crossmatching results. Hla, 2017, 90 (3), pp.157-164. ⟨10.1111/tan.13073⟩. ⟨hal-03574251⟩

Partager

Métriques

Consultations de la notice

6